Skip to Main Content
Try STAT+ TODAY
Trending:
Coronavirus
Health
Biotech
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Pharmalot
STAT+

Up and down the ladder: The latest comings and goings

  • Ed Silverman

By Ed Silverman Oct. 13, 2017

Reprints
Hires -- up and down the ladder
Alex Hogan/STAT

Hired someone new and exciting? Promoting a rising star? Finally solved that hard-to-fill spot?

Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Ed Silverman

Ed Silverman

Pharmalot Columnist, Senior Writer

Ed covers the pharmaceutical industry.

Tags

Experimental flu vaccine, developed using mRNA, seen as potential…
Experimental flu vaccine, developed using mRNA, seen as potential game changer
Why doesn’t the U.S. have at-home flu tests?
Why doesn’t the U.S. have at-home flu tests?
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Q&A: Siddhartha Mukherjee on the rapid pace of cancer…
Q&A: Siddhartha Mukherjee on the rapid pace of cancer research and ‘luminous’ life of cells
Pharmalittle: FDA approves first gene therapy for hemophilia B;…
Pharmalittle: FDA approves first gene therapy for hemophilia B; pharma’s reputation slips in U.S.
Google Cloud pitches ease and speed to lure health…
Google Cloud pitches ease and speed to lure health systems wary of tech changes

Recommended Stories